Literature DB >> 1416614

An FDA perspective of manufacturing changes for products in human use.

C N Durfor1, C L Scribner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416614     DOI: 10.1111/j.1749-6632.1992.tb42598.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  1 in total

1.  Regulatory considerations when developing biological products. Report of the Center for Biologics Evaluation and Research.

Authors:  R W Kozak; C N Durfor; C L Scribner
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.